Jan Vesterbacka

2.4k total citations
25 papers, 495 citations indexed

About

Jan Vesterbacka is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Jan Vesterbacka has authored 25 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 12 papers in Virology and 9 papers in Emergency Medicine. Recurrent topics in Jan Vesterbacka's work include HIV Research and Treatment (12 papers), HIV-related health complications and treatments (8 papers) and HIV/AIDS Research and Interventions (6 papers). Jan Vesterbacka is often cited by papers focused on HIV Research and Treatment (12 papers), HIV-related health complications and treatments (8 papers) and HIV/AIDS Research and Interventions (6 papers). Jan Vesterbacka collaborates with scholars based in Sweden, United States and India. Jan Vesterbacka's co-authors include Piotr Nowak, Anders Sönnerborg, Ujjwal Neogi, Kajsa Noyan, Babilonia Barqasho, Knut Rudi, Johannes R. Hov, Marius Trøseid, Jenny Svärd and Ekaterina Avershina and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Virology.

In The Last Decade

Jan Vesterbacka

24 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan Vesterbacka Sweden	11	268	247	195	170	63	25	495
Nadia Madrid Spain	11	452 1.7×	313 1.3×	396 2.0×	237 1.4×	151 2.4×	15	761
P. D’Argenio Italy	9	280 1.0×	51 0.2×	155 0.8×	96 0.6×	133 2.1×	13	498
Marisela Silva United States	6	537 2.0×	303 1.2×	77 0.4×	147 0.9×	213 3.4×	11	708
Amrei von Braun Germany	13	282 1.1×	67 0.3×	66 0.3×	25 0.1×	202 3.2×	40	569
Christoph C Carter United States	11	532 2.0×	70 0.3×	257 1.3×	478 2.8×	127 2.0×	24	780
Michael J. Borucki United States	12	428 1.6×	57 0.2×	166 0.9×	182 1.1×	274 4.3×	22	632
Maame Efua Sampah United States	10	160 0.6×	80 0.3×	134 0.7×	13 0.1×	88 1.4×	19	497
Penny Neild United Kingdom	12	192 0.7×	112 0.5×	52 0.3×	51 0.3×	387 6.1×	28	847
Sabrina Audagnotto Italy	15	227 0.8×	34 0.1×	134 0.7×	60 0.4×	235 3.7×	38	509
Maria Christine Thurnheer Switzerland	8	150 0.6×	38 0.2×	60 0.3×	66 0.4×	142 2.3×	16	304

Countries citing papers authored by Jan Vesterbacka

Since Specialization

Citations

This map shows the geographic impact of Jan Vesterbacka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Vesterbacka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Vesterbacka more than expected).

Fields of papers citing papers by Jan Vesterbacka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Vesterbacka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Vesterbacka. The network helps show where Jan Vesterbacka may publish in the future.

Co-authorship network of co-authors of Jan Vesterbacka

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Vesterbacka. A scholar is included among the top collaborators of Jan Vesterbacka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Vesterbacka. Jan Vesterbacka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vesterbacka, Jan, Lokeshwaran Manoharan, Puran Chen, et al.. (2024). Exploring the interplay between antiretroviral therapy and the gut-oral microbiome axis in people living with HIV. Scientific Reports. 14(1). 17820–17820. 9 indexed citations

Mendoza, Carmen de, Graham P. Taylor, Antoine Gessain, et al.. (2024). Virology, pathogenesis, epidemiology and clinical management of HTLV-1 infection. Proceedings of the 30th HTLV European research network (HERN 2023). Cineca Institutional Research Information System (Tor Vergata University). 3(1). 61–69. 3 indexed citations

Svensson, Anna‐Karin, Jan Vesterbacka, & Piotr Nowak. (2024). HTLV in Sweden. PubMed. 26(1). 41–47.

Blennow, Ola, et al.. (2023). Successful Combination Treatment for Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Clinical Infectious Diseases. 76(10). 1864–1865. 23 indexed citations

Ray, Shilpa, Jan Vesterbacka, Ola Blennow, et al.. (2023). Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV. npj Biofilms and Microbiomes. 9(1). 104–104. 9 indexed citations

Ambikan, Anoop T., Sara Svensson Akusjärvi, Shuba Krishnan, et al.. (2022). Genome-scale metabolic models for natural and long-term drug-induced viral control in HIV infection. Life Science Alliance. 5(9). e202201405–e202201405. 9 indexed citations

Akusjärvi, Sara Svensson, Shuba Krishnan, Anoop T. Ambikan, et al.. (2022). Peripheral blood CD4+CCR6+ compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals. Communications Biology. 5(1). 357–357. 4 indexed citations

Sperk, Maike, Anoop T. Ambikan, Shilpa Ray, et al.. (2021). Fecal Metabolome Signature in the HIV-1 Elite Control Phenotype: Enrichment of Dipeptides Acts as an HIV-1 Antagonist but a Prevotella Agonist. Journal of Virology. 95(18). e0047921–e0047921. 15 indexed citations

Akusjärvi, Sara Svensson, Anoop T. Ambikan, Shuba Krishnan, et al.. (2021). Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling. iScience. 25(1). 103607–103607. 10 indexed citations

10.

Eimer, Johannes, Jan Vesterbacka, Irina Savitcheva, et al.. (2018). Nonopportunistic infection leading to rapidly progressive dementia in a patient with HIV/AIDS. Medicine. 97(12). e0162–e0162. 6 indexed citations

11.

Vesterbacka, Jan, Javier Sandoval, Kajsa Noyan, et al.. (2017). Richer gut microbiota with distinct metabolic profile in HIV infected Elite Controllers. Scientific Reports. 7(1). 6269–6269. 68 indexed citations

12.

Westling, Katarina, Lars Navér, Jan Vesterbacka, & Erik Belfrage. (2016). Transition of HIV-infected youths from paediatric to adult care, a Swedish single-centre experience. Infectious Diseases. 48(6). 449–452. 21 indexed citations

13.

Vesterbacka, Jan, et al.. (2015). Effects of Co-Trimoxazole on Microbial Translocation in HIV-1-Infected Patients Initiating Antiretroviral Therapy. AIDS Research and Human Retroviruses. 31(8). 830–836. 12 indexed citations

14.

Nowak, Piotr, Marius Trøseid, Ekaterina Avershina, et al.. (2015). Gut microbiota diversity predicts immune status in HIV-1 infection. AIDS. 29(18). 2409–2418. 222 indexed citations

15.

Westling, Katarina, Erik Belfrage, Lars Navér, & Jan Vesterbacka. (2014). [From pediatric to adult clinic through a transition clinic. Experiences of HIV-infected young people who have been ill all their lives].. PubMed. 111(22-23). 1002–3. 1 indexed citations

16.

Vesterbacka, Jan, Piotr Nowak, Babilonia Barqasho, et al.. (2013). Kinetics of Microbial Translocation Markers in Patients on Efavirenz or Lopinavir/r Based Antiretroviral Therapy. PLoS ONE. 8(1). e55038–e55038. 28 indexed citations

17.

Andersson, Lars‐Magnus, Jan Vesterbacka, Anders Blaxhult, et al.. (2013). Lopinavir/ritonavir, atazanavir/ritonavir, and efavirenz in antiretroviral-naïve HIV-1-infected individuals over 144 weeks: An open-label randomized controlled trial. Scandinavian Journal of Infectious Diseases. 45(7). 543–551. 13 indexed citations

18.

Röshammar, Daniel, Ulrika S. H. Simonsson, Håkan Ekvall, et al.. (2011). Non-linear mixed effects modeling of antiretroviral drug response after administration of lopinavir, atazanavir and efavirenz containing regimens to treatment-naïve HIV-1 infected patients. Journal of Pharmacokinetics and Pharmacodynamics. 38(6). 727–742. 3 indexed citations

19.

Josephson, Filip, Leo Flamholc, Magnus Gisslén, et al.. (2009). The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naïve HIV-1 infected patients. European Journal of Clinical Pharmacology. 66(4). 349–357. 16 indexed citations

20.

Vesterbacka, Jan & Anders Eriksson. (2001). A rural ambulance helicopter system in northern Sweden. Air Medical Journal. 20(3). 28–31. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact